Morgan Stanley analyst Adam Jonas maintains Adient (NYSE:ADNT) with a Underweight and raises the price target from $27 to $29.
Reuters Reported Earlier: Citi Nears Sale Of Mexican Bank
https://www.ft.com/content/57538131-a099-4f86-8e50-b972bc839855